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Medicinal plants are the most important source of life saving drugs for most of the 
world’s population. The aim of this study was to assess Tulbaghia violacea as an 
anticancer agent, to determine the antimicrobial activity, anticancer activity, 
antioxidant and total polyphenol activity, cytotoxicity and genotoxicity effects to be 
used in the development of a novel anticancer remedy. Tulbaghia violacea bulb, root 
and leaf extracts were collected, dried and finely ground with aqueous and 
methanol/dichloromethane solvents. The extracts were tested for their growth 
inhibitory effects using the sulforhodamine B assay; genotoxicity activity was 
determined using NucRed Live 647; antimicrobial activity was determined using p-
Iodonitrotetrazolium chloride assay; antioxidant activity was determined using 2,2-
diphenyl-1-picrylhydrazyl assay; and the gallic acid method was used to determine the 
concentration of phenols. The extracts from T. violacea were classified as weak or 
inactive against the human cell lines TK-10 (renal), PC3 (prostate) and HeLa (cervix) 
cancer. Aqueous and methanol/dichloromethane extracts of T. violacea were both 
non-toxic when tested against the WI-38 cell line. The result of the test for genotoxicity 
determination showed that leaf water extract induced the formation of micronuclei and 
could be considered genotoxic. The extract of T. violacea exhibited high antioxidant 
activity compared to the standard. Total phenolic determination showed that water leaf 
extract had the highest concentration of phenolics and bulb methanol/dichloromethane 
extract the lowest. The antibacterial activity showed interesting results with certain 
plant extracts, indicating Gram specificity. Water leaf extracts and water bulb extract 
from T. violacea both showed activity against Klebsiella pneumoniae (Gram-negative) 
but not against Staphylococcus aureus (Gram-positive). Root water extract showed a 
similar result at the lower concentrations. The high concentrations of root 
methanol/dichloromethane extract showed a more drastic increase in the percentage 
cell death of S. aureus than that of K. pneumoniae. Methanol/dichloromethane bulb 
extract also seemed to be effective against S. aureus. The extracts of T. violacea have 
the potential to be developed as an antimicrobial agent, but the standard has higher 
antimicrobial activity. These results indicated the safety and importance of T. violacea 
as a potential for the development of a novel drug. 




















Plants are known to be significant sources of chemotherapeutic agents (Mohammad, 
2006). Medicinal plants play a major role in primary health care in rural areas (Parekh, 
et al., 2006). It has been reported that 65% to 80% of the world’s population rely mainly 
on traditional medicinal plants for the treatment of different diseases and infections 
(WHO, 2002; Tullayakorn et al., 2012). Throughout history, natural products have 
proven to be rich repositories of medicines with different chemical structures and 
bioactive compounds that are effective against many diseases (Tullayakorn et al., 
2012). The use of medicinal plants as treatment has increased rapidly in the past three 
decades (Valli et al., 2002). Rural people in various parts of the world have a universal 
tendency to depend on medicinal plants growing in areas close to them (Tullayakorn 
et al., 2012). Treating infectious diseases with natural products rather than 
conventional drugs is more advantageous and affordable to many patients in the 
Southern African situation, since these products are readily available in the area in 
which they live, and some are cultivated to ensure product quality and safety (Muleya 
et al., 2014). 
 
Skills have been developed and learned over many years, affecting different and 
independent systems of drug use (Engel, 1977). The availability of medical plants and 
the cultural use of plants make this an area of significance for the discovery of 
therapeutic species and ethno-medicinal research (Cox et al., 1994). It is important to 
note that some plant-based remedies are mostly used by traditional people to cure 
easily treated diseases and protect them from many complex diseases (Gurib-Fakim, 
2006). 
 
There is an ongoing need for development of novel drugs that are highly effective in 
the treatment of various diseases, such as cancer (Elham et al., 2014). The 
pharmacological evaluation of plants is a significant means of finding new, safe and 
effective drugs (Farnsworth et al., 1985). Natural products, such as medicinal plants, 
whether used as a pure compound or as a standardised extract, provide unlimited 
possibilities for new drug development because of the unmatched accessibility of 
chemical variety (Sasidharan et al., 2011). 
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A growing number of people are turning to plant-derived medicines and remedies for 
various reasons, which include their low cost compared to Western pharmaceuticals, 
and are looking for natural alternatives, which are widely believed to have fewer side 
effects (Kumar et al., 2003). The traditional medicine industry is a multi-million-rand 
industry in South Africa and is continually growing (Ndhlala et al., 2010). Although the 
Medicines and Related Substances Control Act 101 of 1965 was amended in 2002, 
the regulation of commercially labelled medicines, herbal formulations and nutritional 
supplements is still complex (Ndhlala et al., 2011). Medicine regulation is in the public 
interest and includes three integral aspects: quality, safety and efficacy (Sasidharan 
et al., 2011).  
There are some concerns about the quality of the hygiene and potential contamination 
of traditional products used in herbal medicines, which are sold on pavements and in 
markets where the materials are often exposed to sputum, urine and faeces, 
contrasting with the pharmaceutical manufacturing standards that are required for the 
production and packaging of other medicines (Kunle et al., 2012). In terms of efficacy 
and safety, it is essential to determine the relative risk from traditional African herbs 
and remedies (Ndhlala et al., 2010). 
 
1.2 Drug development 
Innovations in the health sciences have resulted in dramatic changes in the ability to 
treat disease and improve the quality of life (Kazis et al., 1989). The cost of 
pharmaceuticals has grown faster than other key components of the health care 
system since the late 1990s (Grabowski et al., 2002). Therefore, discussions on rising 
health care costs and the development of new therapeutic technologies have focussed 
increased attention on the pharmaceutical industry, which is both a main contributor 
to the health care industry and a main source of advances in health care technologies 
(DiMasi et al., 2003). Furthermore, great ecological awareness has led to increased 
curiosity about natural plant formulations worldwide (Lindemann-Mathies, 2005). The 
effectiveness of many plant preparations has been established by valid 
phytopharmaceutical techniques and the number of herbal-based medicines or health 
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foods has increased progressively to meet the increasing demand (Atta-ur-Rahman et 
al., 2001). 
  
1.2.1 Anticancer activity 
In the 1960s, camptothecin (CPT) was discovered by Wall and Wani as an anticancer 
treatment with an exclusive mode of action, that is, inhibition of deoxyribonucleic acid 
(DNA) topoisomerase I (Wall et al., 1996). This naturally occurring alkaloid was first 
extracted from the stem wood of the Chinese ornamental tree Camptotheca 
acuminata, also known as the ‘tree of joy’ and ‘tree of love’, through the screening of 
thousands of plants in an examination for steroids (Srivastava et al., 2005). Initial 
research discovered significant anticancer activity in a standard in vitro assessment 
system, also in mouse leukaemia cells (Hertel et al., 1990). These astounding 
discoveries stimulated significant interest in this herbal product as a possible 
anticancer agent. Currently, the first-generation analogues of CPT, hycamtin 
(topotecan) and camptosar (irinotecan, CPT-11), marketed by Glaxosmithkline and 
Pfizer, are used for the treatment of ovarian cancer, lung cancer and colon cancer 
(Diwaker et al., 2012). 
The alkaloids, vinblastine and vincristine, from the Madagascar periwinkle, 
Catharanthus roseus (L.) (Apocynaceae), were clinically used as anti-tumour agents, 
among others to treat leukaemia, lymphoma, advanced testicular cancer, breast and 
lung cancer and Kaposi’s sarcoma (Shah et al., 2013). The discovery of paclitaxel from 
the bark of the Pacific yew, Taxus brevifolia (Taxaceae), is another example of herbal 
product treatment discovery (Itokawa et al., 2008). Paclitaxel was reported to be 
important in the treatment of ovarian cancer, advanced breast cancer and lung cancer 
(Shah et al., 2013). In South Africa the root and bark of Combretum caffrum have been 
found to have anticancer properties and it is likely that the combretastatin molecule is 
the most successful cytotoxic phytomolecule identified to date (Pettit et al., 1982; 
Mohammad 2006; Kharb et al., 2012). 
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1.2.2 Antimicrobial activity 
Since ancient times, human beings have used herbs to treat common infectious 
ailments and some plant-based therapy is still included as part of the usual treatment 
of numerous diseases (Ncube et al., 2008). Arctostaphylos uva-ursi and Vaccinium 
macrocarpon have been used to treat urinary tract infections (Bag et al., 2008). The 
essential oils of thyme, origanum, mint, cinnamon, salvia and clove also have 
antimicrobial properties (Rios et al., 2005). 
The roots of Crytolepis sanguinolenta have antimicrobial properties and are also used 
in the treatment of urinary infections (Elujoba et al., 2005). In the Centre for Research 
on Pharmacopoeia and Traditional Medicine in Rwanda, Datura stramonium, 
Eucalyptus globes, Capsicum frutescens and Plantago lanceolate are readily available 
in the dispensary of plant-based remedies (Elujoba et al., 2005). These are 
administered for their antispasmodic, pulmonary disinfectant, counter-irritant and anti-
tussive activities (Elujoba et al., 2005). The root and stem-bark extracts of the two 
Zanthoxylum species have high antimicrobial activity (Rios et al., 2005). The essential 
oils of the eugenol purified from Ocimum gratissimun also have antimicrobial 
properties to treat pneumonia, diarrhoea and conjunctivitis (Khan et al., 2009).  
 
1.2.3 Antioxidant activity 
Free radicals are formed as part of normal metabolic processes, and are unstable and 
very reactive (Valko et al., 2007). Antioxidant enzymatic systems and chemical 
substances such as endogenous enzymes or naturally occurring dietary antioxidants 
and some hormones control the cellular reduction oxidation state (Lobo et al., 2010). 
The increased formation of free radicals overpowers the antioxidant defence and 
enforces oxidative stress on the physiological system (Chong et al., 2017). Too much 
oxidative stress can harm cellular lipids, proteins or DNA by suppressing their normal 
role (Marnett, 2000). The human body naturally continually activates a battery of 
detoxifying enzymes or inhibits the generation of reactive oxygen species (ROS) and 
reactive nitrogen species through several mechanisms, such as antioxidant enzymes 
and molecules (Mates 2009). Numerous synthetic substances, such as vitamins, 
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butylated hydroxy anisole, butylated hydroxytoluene, propyl gallate and tert-
butylhydroquinone are used as antioxidants but are suspected of being toxic to 
humans and experimental animals (Shahidi et al., 2005). Hence, the development of 
new drugs and the use of more effective antioxidants of natural origin are very 
significant. Furthermore, antioxidant evaluation of medicinal plants might yield 
understanding of the mechanism of their pharmacological activities (Olorunnisola et 
al., 2011).  
 
1.3 Tulbaghia violacea 
Tulbaghia violacea Harv. (Figure 1.1) of the family Alliacea is a small perennial 
bulbous herb with corm-like rhizomes and narrowly linear, evergreen aromatic leaves 
(Lyantagaye 2011). The flowers are tubular, mauve or pale purple, occurring in groups 
of about 10 at the tip of the slender stalk (Raji et al., 2012). The plant prefers partial 
shade or full sun and dry to moist soils (Meerow et al., 1993). The developed height 
ranges from 30 cm to 120 cm, depending on environmental circumstances 
(Lyantagaye, 2011). The plant can be grown successfully in a tub and transferred to a 
greenhouse or a frost-free place to overwinter (Saibu et al., 2015). The herb has a 
robust odour of onion or garlic when bruised, hence its common names, wild garlic or 
society garlic (Kubec et al., 2002). Despite its garlic-like flavour, the consumption of T. 
violacea is not accompanied by the development of bad breath (Lyantagaye, 2011). 
This plant is commonly called different names by diverse groups in South Africa, such 
as wild garlic (English), wildeknoffel (Afrikaans), Isihaqa (Zulu) and Moelela (Sotho) 
(Lyantagaye, 2011). 
 
This plant is used in traditional medicine in the Eastern Cape and KwaZulu-Natal for 
treating diseases and clinical symptoms such as fever, colds, asthma, tuberculosis, 
stomach-ache and cancer of the oesophagus (Olorunnisola et al., 2012). The bulbs of 
T. violacea are used as a remedy for pulmonary tuberculosis and to destroy intestinal 
worms (Lyantagaye, 2011; Raji et al., 2012). The Zulu-speaking traditional people use 
the bulb to make an aphrodisiac medicine (Lyantagaye, 2011). Some Rastafarians eat 
copious amounts of this plant and chili during winter, allegedly to keep the blood warm 
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and stop aches and pains (Lyantagaye, 2011). In the Eastern Cape it is used for colic, 
wind, restlessness, headache and fever, largely for young children (Lyantagaye, 
2011). The plant is also used to keep snakes away (Bungu et al., 2008; Adeyemi et 
al., 2013). 
 
Figure 1.1 Tulbaghia violacea plant (https://www.amazon.com/Society-Garlic-Tulbaghia-Violacea-
Gallon/dp/B0789MB71C) 
 
1.4 Aim of the study 
The current study was conducted with the aim of investigating the biological activity 
and phytochemical analysis of aqueous and dichloromethane extracts of T. violacea. 
 
1.5 Objectives of the study 
The objectives of the study were to: 
• conduct in vitro anticancer screening of T. violacea extracts; 
• assess antimicrobial activity of both aqueous and dichloromethane extracts; 
• determine total polyphenol composition of the plant extract; and 
• evaluate the genotoxicity and establish the safety of the plant extracts through 
cytotoxicity assays of both the aqueous and dichloromethane extracts. 
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1.6  Chapter outline 
This study is presented in five chapters. Chapter two presents the anticancer activities 
of the aqueous and dichloromethane extracts from T. violacea using sulforhodamine 
B (SRB) assay. The safety of the plant extract is dealt with in chapter three through 
cytotoxicity assays. The antioxidant activity and the total polyphenol analysis of the 
plant extract are covered in chapter four. The fifth chapter is an assessment of the 
antimicrobial activity of the plant extract against Staphylococcus aureus (ATCC 25923) 
and Klebsiella pneumoniae (ATCC700603) and the sixth chapter presents the 
genotoxicity analysis of the extract. 
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Anticancer screening of Tulbaghia violacea 
 
  






Cancer is a disease of complex aetiology, defined as uncontrolled growth of cells 
(Ruffa et al., 2002). Cancer is a major cause of death registered worldwide by public 
health institutions, exceeded only by cardiovascular diseases (Yaacob et al., 2010). 
Cancer starts with the deformation of a natural cell, triggered by genetic mutations in 
DNA (Ruffa et al., 2002). The World Health Organisation (WHO) has projected that if 
instant action is not taken, the incidence of cancer will be increased by 80% by 2030, 
with most cases occurring in low- and middle-income countries (Khazir et al., 2014). 
External factors (such as tobacco, infectious organisms, chemicals and radiation) and 
internal factors (inherited mutations, hormones, immune conditions and mutations that 
occur from metabolism) are mostly responsible for cancer (Khazir et al., 2014). These 
causal factors may act together or in sequence to initiate or promote the growth of 
cancer (Khazir et al., 2014). The transformation of a normal to a cancerous cell 
involves three distinct phases, namely initiation, promotion and progression (Foulds, 
1954). Cancer is a significant health problem in developing and developed countries 
(Kooti et al., 2017). According to the WHO, 14 million people suffer from cancer and 
8 million die from cancer worldwide annually (Khazir et al., 2014). 
Various methods exist for the treatment of cancer, namely chemotherapy, 
radiotherapy and surgery. Despite being highly efficient, surgery is not always practical 
under all circumstances (Asadi-Samani et al., 2016). For radiotherapy, systemic 
radiotherapy is conducted in various ways, including external radiation therapy, 
brachytherapy and internal radiation therapy (Pijls-Johannesma et al., 2010). The 
effect of therapy leads to changes in skin health, such as alopecia and destruction of 
epithelial cells (scaling) and epithelial moisture (dermis revealing and skin secretion of 
serous fluid) and potentially to mouth ulcers and complications, bone marrow 
suppression and development of anaemia, leukopenia and thrombocytopenia (Asadi- 
Samani et al., 2016). Chemotherapy treatments, including antimetabolites (such as 
methotrexate), inactive material of DNA (such as cisplatin and doxorubicin), antitubulin 
agents (such as taxis), and hormones that are most often used cause unwanted 
effects, including hair loss, bone marrow suppression, drug resistance, gastric ulcers, 
neurological dysfunction and cardiac toxicity (Majid et al., 2016). Most cancer 
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chemotherapies severely affect the host’s normal cells (Maeda et al., 2009). The most 
significant problem in cancer treatment is destroying tumour cells among natural cells, 
without harming the natural cells (Kooti et al., 2017). These available cancer 
treatments are expensive and inaccessible to people living in resource-limited and 
poor communities (Takaidza et al., 2018). 
 
The use of medicinal plants is considered as of outstanding value in cancer treatment 
(Mans et al., 2000). Cancer is one of the most prominent ailments in humans and at 
present there is significant scientific and commercial interest in the discovery of new 
anticancer agents from natural products. Natural products such as flavonoids, 
terpenes, alkaloids, etc. have received significant attention in recent years owing to 
their various pharmacological properties, including cytotoxicity and anticancer features 
(Shaktikumar et al., 2011). Only a few of them have been scientifically proven to have 
potent abilities to treat cancer (Couzin-Frankel, 2013).  The probability of using natural 
products as anticancer agents was recognised in the 1950s by the US National Cancer 
Institute, which has since made major contributions to the discovery of new naturally 
occurring anticancer agents (Fouché et al., 2008). South Africa’s rich plant 
biodiversity, with over 20 000 different species, is an excellent source of interest to the 
scientific community (Turpie, 2003). Despite the approach of using natural products to 
develop anticancer drugs, reports on plants used for the treatment of cancer are rare 
in South Africa (Fouché et al., 2008). Natural products are known to serve as a helpful 
source of cancer chemo-preventive agents (Pezzuto, 1997). There is a possibility that 
regular use of medicinal plants could reduce the incidence of cancer by inhibiting the 
development of carcinogenesis (Ruffa et al., 2002). However, many drugs of natural 
origin still need to be investigated as new anticancer agents, to increase the range 
obtainable and to discover less toxic and more effective drugs. Samples with 
pharmacological usage should be considered when selecting plants to treat cancer, 
as some ailments reproduce disease states of significance to cancer or cancer-like 
symptoms (Bellamy et al., 1990). 
 
 
Prostate cancer is a leading cause of cancer-related death in males (Jemal et al., 
2005). Prostate cancer has surpassed lung cancer as the most common cancer in 
men (Mohler et al., 2010). A relatively low death rate suggests that increased public 
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awareness, with earlier detection and treatment, has started to affect mortality from 
this common cancer (Mohler et al., 2010). However, early detection and treatment of 
prostate cancers that do not threaten life expectancy result in unnecessary side effects 
(Mohler et al., 2010). Prostate tumours are particularly heterogeneous, i.e. composed 
of cells with different phenotypic characteristics and different proliferative and 
malignant potentials (Collins et al., 2005). In leukaemia and some solid cancers, only 
a small subset of cells is clonogenic in culture and in vivo (Collins et al., 2005). 
Androgen deprivation therapy plays an essential role in the management of locally 
advanced, recurrent and metastatic prostate cancer (Collins et al., 2005).  
 
However, most patients go on to develop androgen-independent disease that remains 
incurable by current treatment strategies (Collins et al., 2006). Prostate-specific 
antigen (PSA) in combination with digital rectal analysis forms the basis for current 
prostate cancer screening programmes (Mohler et al., 2010). However, PSA 
examination has recently proven to reduce prostate cancer-specific mortality. Its 
limitations include the risk of unnecessary prostate biopsy and the diagnosis and 
treatment of cancers that might never have been symptomatic (Mohler et al., 2010). 
The exact diagnosis of clinically significant prostate cancer remains a challenge 
(Kelloff et al., 2009). Investigation of a correlation between the PSA level and biopsy 
results in the placebo group of a recent trial indicates that there is no normal PSA level 
(Mohler et al., 2010). Acknowledging that the PSA level is a continuum rather than a 
dichotomous marker makes accurate diagnosis of clinically significant prostate cancer 
even more challenging (Mohler et al., 2010). 
 
Renal cell carcinoma (RCC) includes a diverse group of solid cancers originating from 
renal parenchyma. RCC, with a worldwide rising occurrence, is the seventh most 
common tumour in men and the ninth most common in women and constitutes about 
2%-3% of adults’ malignancies (Hirbod-Morabakeh et al., 2017). RCC caused more 
than 140 000 deaths globally in 2012 (Hirbod-Morabakeh et al., 2017). RCC arises 
from the renal epithelium and comprises approximately 80% of all kidney cancers 
(Drucker, 2005). The original treatment for localised RCC is surgery, but 20%-40% of 
patients characteristically relapse, with a median time to relapse of one to two years 
(Hudes et al., 2011). In addition, about one third of RCC patients present with 
metastatic disease (Elson et al., 1988). Until recently, patients with RCC whose 
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disease had become metastatic had few treatment options (Albiges et al., 2012). 
Therefore, patients treated with targeted therapies need close monitoring with specific 
management algorithms established to improve patient benefit (Hudes et al., 2011). 
Patients with RCC may show local or systemic symptoms, although most symptoms 
are related owing to the widespread use of abdominal imaging (Escudier et al., 2010). 
Cervical cancer is the third most diagnosed cancer and the fourth leading cause of 
cancer death in women globally; approximately 85% of these deaths happen in 
developing nations (Nour, 2009; Khaled, 2014; Sawadogo et al., 2014). Cervical 
cancer has a great societal impact because it mainly affects females from their 30s to 
their 50s, who are frequently raising or supporting families (Sawadogo et al., 2014). 
Thus far, cervical cancer has remained a common source of tumour death in women 
in developing countries lacking access to screening (Pap test) or vaccines against 
human papilloma virus (Vizza et al., 2018). Persistent human papillomavirus infection 
is frequently associated with the development of cervical intraepithelial neoplasia 
grade 3 or carcinoma in situ “precancer”, which can lead to cervical cancer (Sawadogo 
et al., 2014).  
 
Because of complications with the therapies currently available for treatment of 
cancer, the high cost of conventional therapies and the growing incidence of cancer in 
both developed and developing countries (Collins et al., 2005), it seems necessary to 
develop more novel approaches with higher efficiency to decrease the disease 
intensity (Collins et al., 2005). In this regard, there is considerable scientific and 
commercial interest in developing new anticancer agents from natural sources (Collins 
et al., 2005). The development of new anticancer drugs has been turned into a 
significant research area. Researchers have attempted to find naturally derived 
combinations to synthesise new drugs to treat the disease (Collins et al., 2005; Patel 
et al., 2018). Plants have a long history of use in the treatment of cancer (Cragg et al., 
2005). It is important that over 60% of currently used anticancer agents are derived in 










2.2.1 Plant collection, preparation and extraction 
 
The plant material of T. violacea was authenticated by scientists at the National 
Botanical Garden in Bloemfontein, South Africa. The collected material was washed 
to remove soil and then separated into leaves, bulbs and roots. The plant parts were 
oven-dried at 30-60ºC for five days. The dried plant parts were ground to a coarse 
powder using a hammer mill and stored at ambient temperature prior to extraction. 
 
The dried and ground plant materials were blended in part of the extraction solvent 
(water and methanol/dichloromethane 1:1) using the Waring blender. After blending 
the rest of the solvent was added and solutions were allowed to steep for 24 h. After 
24 h the solids were removed from each solution by filtration with a Millipore funnel 
with medium filter paper (Bright sign no 102) connected to a Millipore vacuum pump. 
Organic extracts were concentrated by rotary vacuum at 50-60ºC, then further dried 
in vacuo at ambient temperature. The aqueous extracts were concentrated to dryness 
using a freeze-dryer. The six plant extracts (Table 2.1) were stored at -20 ºC until 
further use. 
 
Table 2.1: Extraction of Tulbaghia violacea with methanol/dichloromethane and water 
solvents 
Sample No. Part Extraction solvent Yield (g) 
1 Leaves Methanol/dichloromethane 
(1:1) 
6.2716 
2 Leaves Water 7.1516 
3 Bulbs Methanol/dichloromethane 
(1:1) 
4.8616 
4 Bulbs Water 6.8882 
5 Roots Methanol/dichloromethane 
(1:1) 
6.2868 
6 Roots Water 3.4951 
 
 
© Central University of Technology, Free State
20 
 
2.2.2 Sulforhodamine B assay 
 
The SRB assay was used to measure the growth inhibitory effects of the investigated 
plant extracts. The SRB is based on the ability of the protein dye SRB (Acid Red 52) 
to bind electrostatically in a pH-dependent manner to protein-basic amino acid 
residues of trichloroacetic acid-fixed cells. Under mild acidic conditions it binds to the 
fixed cellular protein, while under mild basic conditions it can be extracted from cells 
and solubilised for measurement. The SRB assay was performed at the Council for 
Scientific and Industrial Research (CSIR) in accordance with the protocol of the Drug 
Evaluation Branch, the National Cancer Institute (NCI). 
 
The human cell lines TK10 and PC-3 were obtained from the NCI in the framework of 
a collaborative research programme between the CSIR and the NCI. The growth 
inhibitory effects of the plant extracts were tested in the three cell lines panel consisting 
of TK10 (renal), PC-3 (prostate) and HeLa (cervix) cancer cells by SRB assay. Cell 
lines were routinely maintained as a monolayer cell culture at 37ºC, 5% CO2, 95% air 
and 100% relative humidity in Roswell Park Memorial Institute containing 5% foetal 
bovine serum, 2 mM L-glutamine and 50 µg/ml gentamicin. For the screening 
experiment, the cells (3-19 passages) were inoculated in 96-well microtiter plates at 
plating densities of 7-10 000 cells/well and were incubated for 24 h. After 24 h the cells 
were treated with the experimental plant extracts, which had previously been dissolved 
in dimethyl sulfoxide (DMSO) and diluted in medium to produce five concentrations. 
Cells to which no drug had been added served as control. The blank contained 
complete medium without cells. Parthenolide was used as a standard. The plates were 
incubated for 48 h after addition of the plant extracts. Viable cells were fixed to the 
bottom of each well with cold 50% trichloroacetic acid, washed, dried and dyed by 
SRB. Unbound dye was removed, and protein-bound dye was extracted with 10 mM 
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2.2.2.1 Statistical assay 
 
Data analysis was performed using GraphPad Prism software. The cell growth 
activities of the plant extracts were presented as IC50 (concentration required to attain 
50% radical-scavenging effect) values and were divided into four categories (Table 
2.2). Fifty percent of cell growth inhibition (IC50) was determined by non-linear 
regression. 
 
Table 2.2: CSIR standard criteria for anticancer activity 
 IC50, µM Status IC50, µg/ml Status 
 > 100  Inactive > 100  Inactive 
 < 100  Weak  < 100 Weak  
 > 50    >15    
 < 50  Moderate  < 15  Moderate 
 >10    > 6.25   




2.3 Results and discussion 
 
The anticancer activity of the crude extracts from T. violacea against cancer cell lines 
and the normal human foetal lung fibroblast cell lines were determined and presented 
in Tables 2.3-2.9. The CSIR anticancer activity criteria (Table 2.2) was used to 
interpret and categorise the activities observed. Therefore, the aqueous and 
methanol/dichloromethane leaf, root and bulb extracts of T. violacea were tested 
against TK10, PC3 and HeLa cancer cell lines. An extract was considered inactive if 
the IC50 value for two or three cell lines was more than 100 µg/ml. An extract with an 
IC50 value greater than 15 µg/ml but less than 100 µg/ml when tested against two or 
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100 2.0 3.89 0.38 0.40 0.13 10.42 0.65 
10 1.0 3.35 1.54 12.31 0.01 35.80 0.33 
1 0.0 92.27 2.28 93.04 1.15 101.27 0.45 
0.1 -1.0 105.03 0.25 100.87 0.80 99.64 2.71 
0.01 -2.0 102.81 1.78 101.95 0.74 100.86 1.45 
 
 TK-10 PC-3 HeLa 
IC50, 
μg/ml  2.658 3.710 7.483 
 
The parthenolide (standard) was tested against three cell lines, namely TK-10, PC-3 
and HeLa. The standard drug (Parthenolide) (Table 2.3) had potent anticancer activity 
with an IC50 value of less than 6.25 µg/ml for all three cell lines.  The control results 
obtained correlated with olive leaf extract, which showed a very strong reduction of 
cell viability in cervical cancer cells when treated with Parthenolide (Vizza et al., 2019).  
Therefore, the growth inhibitory effects of the plant extracts were then tested on the 
three cell lines panel consisting of TK10 (renal), PC-3 (prostate) and HeLa (cervix) 
cancer cells by SRB assay and compared to the control Parthenolide known activity. 
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Table 2.4: Anticancer activity of methanol/dichloromethane (1:1) leaf extract from 
Tulbaghia violacea on three human cell lines: TK10, PC3 and HELA. 




















100 2.0 76.19 0.50 73.27 3.89 78.38 1.69 
10 1.0 85.10 0.37 91.86 2.45 95.35 3.68 
1 0.0 92.87 0.83 96.24 3.58 99.99 0.70 
0.1 -1.0 95.99 0.05 97.63 1.36 99.26 4.52 
0.01 -2.0 99.29 1.02 100.57 0.49 100.01 2.96 
 
 TK-10 PC-3 HeLa 
IC50, 
μg/ml  >100 >100 >100 
 
The methanol/dichloromethane leaf extract was tested against three cell lines, TK-10, 
PC-3 and HeLa. The extracts’ activity was generally weak; however, there was 
noticeable anti-cancer activity against PC-3 compared to TK-10 and PC-3. The results 
in Table 2.4 show that methanol/dichloromethane (1:1) leaf extract was inactive for all 
cell lines. In order to achieve 50% inhibition of the viable cells there was a need of > 
100 ug/ml. This simply indicated that the performance of the extract was weak 
compared to the control used, as shown in table 2.3. The results obtained from the 
methanol/dichloromethane leaf extract differed from the published results of the study 
on the methanol leaf extract. It showed growth inhibition in HeLa and the three different 
cell lines, namely HT-29(colon cancer), MCF-7 (breast cancer and WHCO3 
(oesophageal cancer), though a different solvent was used (Bungu et al., 2006).  
 
Table 2.5: Anticancer activity of water leaf extract from Tulbaghia violacea on three 












% Viability  
HeLa SD 
 
100 2.0 40.17 0.17 32.52 1.81 38.80 1.27 
10 1.0 83.00 0.64 83.93 0.05 88.17 0.22 
1 0.0 89.68 0.26 96.84 0.02 95.03 0.15 
0.1 -1.0 98.99 0.08 97.57 0.04 98.15 0.44 
0.01 -2.0 101.24 0.11 97.44 0.23 100.63 0.89 
 
 TK-10 PC-3 HeLa 
IC50, μg/ml  62.37 49.14 64.8 
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The water leaf extract from T. violacea was tested against three human cell lines, 
namely TK10, PC-3 and HeLa. The results in Table 2.5 show that water leaf extract 
was weak for all cell lines; to obtain 50% inhibition of the viable cells there was a need 
of 62.37 ug/ml for TK-10, 49.14 ug/m l for PC-3 and 64.8 ug/ml for HeLa. The water 
leaf extract showed more activity when tested against TK-10 compared to PC-3 and 
HeLa human cell lines. The water leaf extract proved to have a better inhibitory effect 
on the PC-3 cell line compared to the other two cell lines. The results obtained from 
the water leaf extract did not correlate with the results published from the study, which 
showed water leaf extract of Tulbaghia violacea to have better inhibition with high 
significance between different concentrations on the human oral cell line (Takaidza et 
al., 2018).  
 
Table 2.6: Anticancer activity of methanol/dichloromethane (1:1) bulb extract from 












% Viability  
HeLa SD 
 
100 2.0 82.55 0.10 69.00 1.39 77.92 0.79 
10 1.0 93.42 0.29 93.29 0.35 92.27 0.95 
1 0.0 97.48 0.05 91.78 0.20 98.05 0.99 
0.1 -1.0 97.52 0.01 95.65 1.78 98.36 0.21 
0.01 -2.0 101.24 0.61 97.24 2.38 98.72 0.50 
 
 TK-10 PC-3 HeLa 
IC50, μg/ml  >100 >100 >100 
 
The methanol/dichloromethane bulb extract was tested against three cell lines, TK-10, 
PC-3 and HeLa. All the bulb extracts’ activity was weak, though anticancer activity PC-
3 was better compared to TK-10 and PC-3. It is suggested that the concentration of 
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Table 2. 7: Anticancer activity of water bulb extract from Tulbaghia violacea on three 











% Viability  
HeLa SD 
 
100 2.0 53.02 0.41 57.63 0.03 57.46 1.49 
10 1.0 87.61 0.96 77.65 0.06 95.72 0.08 
1 0.0 94.18 0.77 95.96 0.00 98.67 0.07 
0.1 -1.0 98.18 0.28 98.36 0.16 103.52 0.80 
0.01 -2.0 98.10 0.09 102.06 0.16 104.09 0.14 
 
 TK-10 PC-3 HeLa 
IC50, 
μg/ml  >100 >100 >100 
 
The water bulb extract from T. violacea was tested against three human cell lines, 
namely TK10, PC-3 and HeLa, and the water bulb extracts were active. The water 
bulb extract showed more activity when tested against PC-3 compared to TK-10 and 
HeLa human cell lines (Table 2.7). The water bulb extract showed the least activity 
when tested against TK-10 cells.  
 
Table 2.8: Anticancer activity of methanol/dichloromethane (1:1) root extract from 












% Viability  
HeLa SD 
 
100 2.0 84.44 0.49 76.57 0.17 85.00 0.68 
10 1.0 100.63 0.12 92.50 0.70 96.24 0.00 
1 0.0 103.76 2.80 99.27 0.27 97.06 0.01 
0.1 
-
1.0 101.36 0.72 100.22 0.15 99.56 0.04 
0.01 
-
2.0 102.56 3.19 100.10 0.68 100.29 0.41 
 
 TK-10 PC-3 HeLa 
IC50, 
μg/ml  >100 >100 >100 
 
The methanol/dichloromethane root extract was tested against three cell lines, TK-10, 
PC-3 and HeLa. All the root extracts showed weak activity, though PC-3 reacted better 
compared to TK-10 and PC-3. The root extracts showed weak activity when tested 
against the TK-10 cell line. It is suggested that the concentration of extract be 
increased to stimulate better results (Table 2.8).  
 
 




Table 2.9: Anticancer activity of water root extract from Tulbaghia violacea on three 











% Viability  
HeLa SD 
 
100 2.0 60.19 0.49 52.52 0.01 54.54 0.74 
10 1.0 87.76 0.19 86.66 1.11 86.54 0.21 
1 0.0 89.90 0.42 88.02 0.30 90.58 0.61 
0.1 
-
1.0 106.13 0.68 91.72 0.66 98.95 3.08 
0.01 
-
2.0 103.68 4.59 97.99 0.01 99.55 2.22 
 
 TK-10 PC-3 HeLa 
IC50, 
μg/ml  >100 >100 >100 
 
The water root extract from T. violacea was tested against three human cell lines, 
namely TK10, PC-3 and HeLa and was active in all cases. The root extracts were 
more active when tested against PC-3 compared to TK-10 and HeLa human cell lines. 
The root extracts showed the least activity when tested against the TK-10 cell line.  
 
Table 2.10: Summary of anticancer activity of the extracts from T. violacea 
                    
No. Sample Solvent IC50 for  
TK-10, µg/ml 
IC50 for  
PC-3, µg/ml 




hane (1:1) >100 >100 >100 
2 Leaves Water 62.37 49.14 64.8 
3 Bulbs 
Methanol/dichloromet
hane (1:1) >100 >100 >100 
4 Bulbs Water >100 >100 >100 
5 Roots 
Methanol/dichloromet
hane (1:1) >100 >100 >100 
6 Roots Water >100 >100 >100 
 Parthenolide Standard 2.658 3.710 7.483 
  
 
The aqueous and methanol/dichloromethane leaf, bulb and root extracts from T. 
violacea at equal ratios were tested against three cell lines, TK-10, PC-3 and HeLa, 
as shown in Table 2.10. The methanol/dichloromethane leaf extracts from T. violacea 
were weak when tested against TK-10, PC-3 and HeLa cancer cell lines. The aqueous 
leaf extracts showed inhibition activity when tested against TK-10, PC-3 and HeLa 
cancer cell lines. The methanol/dichloromethane bulb extracts were weak when tested 
against TK-10, PC-3 and HeLa cancer cell lines. The aqueous bulb extracts were also 
weak when tested against TK-10, PC-3 and HeLa cancer cell lines. The 
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methanol/dichloromethane root extracts were weak when tested against TK-10, PC-3 
and HeLa cancer cell lines. The aqueous root extracts also proved to be weak when 
tested against TK-10, PC-3 and HeLa cancer cell lines. The aqueous leaf extract from 
T. violacea showed better inhibition activity against HeLa, followed by TK-10, then PC-
3 cancer cell lines. The leaf extracts showed the best activity when compared to root 
extracts and bulb extracts. These anticancer activity results indicate that the leaf is the 
best part of the plant to use to conduct further testing of TK-10, PC-3 and HeLa. The 
water solvent is still the best solvent to use to test the three cell lines, with increased 
concentration of the plant extracts. The water extracts from T. violacea showed better 
inhibition activity; this correlates with the fact that traditional healers are using water 
to perform extraction.  
 
 2.4 Conclusion 
 
The extracts from T. violacea were generally weak or inactive against the human cell 
lines TK-10 (renal), PC3 and HeLa, as shown in Table 2.2-Table 2.9. A higher 
concentration is suggested to test these three human cell lines against aqueous and 
methanol/dichloromethane extracts. The aqueous solvent proved to be the solvent of 
choice to perform extraction on the T. violacea plant. Also, the leaf extract would be 
the best part of the plant to test against TK-10, PC-3 and HeLa human cell lines. The 
values of IC50 for two to three cell lines show inactivity (>100 µg/ml) of T. violacea 
plant extracts. Acokanthera and Gomphocarus are causes of cardiac glycosides and 
are widely used throughout Africa as a traditional source of extremely toxic arrow 
poisons. Kalanchoe paniculate, Kalanchoe thyrstflora and Coryledon cuneate (0.4% 
hit rate), of the family Crassulaceae, are described as containing bufadienolides and 
these are toxic to livestock and a source of the serious poisoning syndrome known as 
nenta or krimpiekte (Fouche et al., 2008). The aqueous extract of leaves supports the 
claim made by traditional healers for their use of the T. violacea plant for the treatment 
of cancer and other diseases. Further testing using other cell lines is required, also to 
identify the active compounds of T. violacea plant extracts. 
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Cytotoxicity and genotoxicity evaluation of Tulbaghia 





















Many South Africans depend on plant-based medicine for their primary health care 
needs (Srivastava et al., 1996). Unsuitable methods of collection, processing and 
storage, including unwanted contaminants in the products, have contributed to the 
negative view of African natural plant products competing on worldwide markets 
(Mulaudzi et al., 2017). The dependence of such a great portion of people on herbal 
remedies can be attributed to several factors, such as moderately good availability of 
the herbs, affordability and wide indigenous knowledge and knowledge among the 
local people (Street et al., 2008). Secondary metabolites obtained from herbs are not 
benign molecules (Sahoo et al., 2010). In various nations treated, packaged and 
labelled medicinal plants are offered commercially, though in South Africa this is a 
novel trend that has thrived owing to variations in the socio-economic structure. 
Several medicinal plants have consequently been registered commercially (Madikizela 
et al., 2017). Herbs have demonstrated chemical defence to prevent disease, or 
destroy threatening species (Dossey et al., 2001). 
 
Toxic substances from herbs can disturb the entire spectrum of vital human organs. 
Some may disturb important functional body systems such as the central nervous 
system (CNS) by interfering with the management of the nerve functions of the body 
(Gurib-Fakim, 2006). The most dominant toxins are neurotoxins that disturb the brain 
and CNS, followed by cytotoxins and metabolic toxins that disturb organs such as the 
kidneys, liver, heart and lungs (Li et al., 2011). The harshness of a toxic effect will 
depend on the route of administration, growth phase or part of the herb, the quantity 
used, the species and the vulnerability of the target (Miltruprabu et al., 2017). Further 
factors that may have an impact on the harshness of toxins include the solubility of the 
toxin in body fluids, the occurrence of intoxication and the age of the target (Ndhlala 
et al., 2013). 
 
Genotoxicity refers to the destructive effect that a compound or extract has on the 
nuclear material of the cell, causing mutations in the cell (Asharani et al., 2009). To 
test whether a compound is genotoxic, the end-point assays used detect DNA damage 
(Moller et al., 2000). A feature of a genotoxic compound is the resulting formation of 
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micronuclei after treatment of cells with the genotoxin (Van Goethem et al., 1997). 
Micronuclei are extra-nuclear bodies that contain damaged chromosome fragments 
and/or whole chromosomes that have not been incorporated into the nucleus after cell 
division (Terradas et al., 2010). The formation of micronuclei can lead to cell death, 
genotoxic instability and cancer development (Luzhna et al., 2013). While treated 
commercial medicinal plants sold in South Africa are prepared according to recipes 
and packaged like Western medicine, it is of concern that they are still not subject to 
enough safety and quality controls (Fennell et al., 2004). According to Madike et al. 
(2020) the water leaf extracts of T. violacea established variable selective toxicity 
towards HepG2, MCF7, H157, HT29 and KMST6, which are not cancer cell lines. It 
would consequently be imprudent to assume that plant extracts are invariably safe 
(Davey et al., 2002). The guidelines for plant-based medicine incorporate three 
important features: quality, safety and efficacy (Street et al., 2008). 
 
3.2 Aim of the study 
The current study was conducted with the aim of investigating the cytotoxicity activity 
and genotoxicity activity of T. violacea aqueous and dichloromethane extracts. 
 3.3 Methodology 
 
3.3.1 Plant material 
 
T. violacea plant material was authenticated by scientists at the National Botanical 
Garden in Bloemfontein, South Africa. The collected material was washed to remove 
soil and then separated into leaves, bulbs and roots. The plant parts were oven-dried 
at 30-60ºC for five days. The dried plant parts were ground to a coarse powder using 




The dried and ground plant materials were blended in part of the extraction solvent 
(water and methanol/dichloromethane 1:1) using the Waring blender. After blending 
the rest of the solvent was added and solutions allowed to steep for 24 h. After 24 h 
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the solids were removed from each solution by filtration with a Millipore funnel with 
medium filter paper (Bright sign no 102) connected to a Millipore vacuum pump. 
Organic extracts were concentrated by rotary vacuum at 50-60ºC, then further dried 
in vacuo at ambient temperature. The aqueous extracts were concentrated to dryness 
using a freeze-dryer. The plant extracts generated were stored in a cold room at -20ºC 
until further use. 
 
3.3.3 Cytotoxicity assay 
The cytotoxic effects of the compounds were tested by SRB assay on the WI38 cell 
line. The SRB assay was used to measure drug-induced cytotoxicity. Its principle is 
based on the ability of the protein dye SRB (Acid Red 52) to bind electrostatically in a 
pH-dependent manner to protein basic amino acid residues of trichloroacetic acid-
fixed cells. Under mild acidic conditions it binds to the fixed cellular protein, while under 
mild basic conditions it can be extracted from cells and solubilised for measurement. 
The SRB assay was performed at the CSIR in accordance with the protocol of the 
Drug Evaluation Branch, NC. 
 
The WI-38 cell line - normal human foetal lung fibroblast from the European Collection 
of Authenticated Cell Cultures - was routinely maintained as a monolayer cell culture 
at 37ºC, 5% CO2, 95% air and 100% relative humidity in Eagle’s Minimal Essential 
Medium containing 10% foetal bovine serum, 2 mM L-glutamine and 50 µg/ml 
gentamicin. For the screening experiment, the cells (21-50 passages) were inoculated 
in 96-well microtiter plates at plating densities of 10 000 cells/well and were incubated 
for 24 h. After 24 h, the cells were treated with the experimental drugs, which had 
previously been dissolved in DMSO and diluted in medium to produce five 
concentrations: 100,10, 1, 0.1 and 0.01 µg/ml. Cells to which no drug had been added 
served as control. The blank contained complete medium without cells. Emetine was 
used as standard at different concentrations: 100,10, 1, 0.1 and 0.01 µg/ml. The plates 
were incubated for 48 h after addition of the compounds. Viable cells were fixed to the 
bottom of each well with cold 50% trichloroacetic acid, washed, dried and dyed by 
SRB. Unbound dye was removed, and protein-bound dye was extracted with 10 mM 
Tris base for optical density determination at a wavelength of 540 nm using a multi-
well spectrophotometer.  




3.3.4 Genotoxicity assay 
The NucRed Live 647 Probe (ThermoFischer Scientific) is a far red, cell-permeant 
nuclear stain for live and dead cells. It was used to determine the formation of 
micronuclei. Vero cells (African green monkey kidney cells) were seeded at 4 000 
cells/well and left overnight to attach. The cells were treated with different 
concentrations of each extract: 200, 100, 50, 25 and 12.5 µg/ml. Cells were treated for 
48 h (incubated at 37˚C). Medium and treated cells were aspirated and stained with 
NucRed by preparing NucRed working solution. Two drops of NucRed per ml PBS 
(+Ca +Mg) were added. In both the aspirate medium and treatments, 100 μl NucRed 
working solution was added to each well and incubated for 15 – 30 minutes at 37°C. 
The plates were examined using the ImageXpress XLS microscope. 
 
3.3.5 Statistical analysis 
 
Data analysis was performed using GraphPad Prism software. The cell growth 
activities of the plant extract were reported as IC50 values and were divided into four 
categories. Fifty percent (50%) of cell growth inhibition (IC50) was determined by non-
linear regression. 
 
3.4 Results and discussion of cytotoxicity 
 
The analysis of the different extracts was performed according to the CSIR criteria 
(Table 3.1). An extract with an IC50 value of less than 100 µg/ml but greater than 
30 µg/ml when tested against a cell line was considered weakly cytotoxic (Table 3.1). 
An extract with an IC50 value of less than 30 µg/ml but greater than 5 µg/ml was 
considered moderately cytotoxic (Table 3.1). An extract with an IC50 of less than 
5 µg/ml was considered highly hazardous. 
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 > 100   Low Hazard 
 < 100  Weak Hazard  
 > 30    
 < 30  Moderate Hazard 
 >5    




Determination of 50% inhibition concentration (IC) 
 
Table 3.2 Emetine standard 




Conc. % Viability SD 
 
100 2.000 15.24 0.38 
10 1.000 25.25 0.09 
1 0.000 83.31 0.42 
0.1 -1.000 98.70 0.70 
0.01 -2.000 99.29 1.49 
 
 
Emetine was used as a control to determine 50% inhibition concentration against WI-
38 cell lines at different concentration. The control was considered moderately toxic at 
a concentration of 100 µg/ml and 10 µg/ml for WI-38 cell lines, whereas the control at 
the lower concentrations was considered non-toxic against WI-38 cell lines with an 
IC50 value of greater than 5 µg/ml for WI-38 cell lines (Table 3.2). This suggests that it 
will be best to consider using lower concentrations of the Emetine standard when 
determining 50% inhibition against WI-cell lines. 
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Table 3.3 Cytotoxicity assay of methanol/dichloromethane (1:1) leaf extract from 





Conc. % Viability SD 
 
100 2.0 87.67 2.85 
10 1.0 98.43 2.24 
1 0.0 99.62 1.61 
0.1 -1.0 100.58 2.25 
0.01 -2.0 100.65 0.81 
 
 
The methanol/dichloromethane leaf extract from T. violacea was tested against the 
WI-38 cell line from a higher concentration to a lower concentration. The results 
obtained were >5 μg/ml from the higher concentration to the lower concentration, as 
shown in Table 3.3. These results indicated that the methanol/dichloromethane leaf 
extracts from T. violacea were non-toxic when tested against the WI-38 cell line (Table 
3.3). The results obtained do not correlate with another study done in South Africa, 
where it was found that ethanol leaf extract was toxic to the murine macrophage cell 
line (Madike et al., 2020). The results support the hypothesis that the leaf extracts’ 
cytotoxicity is purely dependent on the concentrations, type of extract and the cell lines 
used (Madike et al., 2020).  The T. violacea ethanolic extract of the leaves in a study 
done in South Africa was toxic to murine macrophage cells even at the lowest 
concentration of 10 mg/ml;  this simply indicated no correlation, although these results 
correlated with the control results (Madike et al., 2020).  
 






Conc. % Viability SD 
 
100 2.0 74.28 1.66 
10 1.0 98.84 0.96 
1 0.0 100.59 1.51 
0.1 -1.0 100.97 2.31 
0.01 -2.0 100.32 2.23 
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The water leaf extracts from T. violacea were tested against the WI-38 cell line at 
different concentrations. In order to achieve 50% inhibition, a concentration higher 
than 5 μg/ml was necessary, as shown in Table 3.4. These results indicated that the 
water leaf extracts from T. violacea were non-toxic when tested against the WI-38 cell 
line (Table 3.4).  This further supports the study done in South Africa that showed that 
T. violacea leaf extracts’ cytotoxic inhibition effect is purely dependent on the type of 
solvent and the cell line used (Madike et al., 2020). This was also seen even though 
the same plant and solvent were used; because of the different cell lines, namely 
murine macrophage and WI-38 used for testing, the results did not correlate at all 
(Madike et al., 2020). 
 
Table 3.5 Cytotoxicity assay of methanol/dichloromethane (1:1) bulb extract from 





Conc. % Viability SD 
 
100 2.0 82.52 1.06 
10 1.0 99.15 2.23 
1 0.0 100.26 1.91 
0.1 -1.0 97.89 4.05 
0.01 -2.0 100.83 2.42 
 
The methanol/dichloromethane bulb extracts from T. violacea were tested on the WI-
38 cell line from a higher concentration to a lower concentration. The results obtained 
were >5 μg/ml from the higher concentration to the lower concentration, as shown in 
Table 3.5. These results indicated that the methanol/dichloromethane bulb extracts 
from T. violacea were non-toxic when tested against the WI-38 cell line (Table 3.5). 
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Conc. % Viability SD 
 
100 2.0 75.05 0.17 
10 1.0 92.47 0.73 
1 0.0 99.62 0.16 
0.1 -1.0 97.00 0.09 
0.01 -2.0 100.62 0.40 
 
The water bulb extracts from T. violacea were tested on the WI-38 cell line from a 
higher concentration to a lower concentration. The results obtained were >5 μg/mL 
from the higher concentration to the lower concentration, as shown in Table 3.6. These 
results indicated that the water bulb extracts from T. violacea were non-toxic when 
tested against the WI-38 cell line (Table 3.6). 
 
Table 3.7 Cytotoxicity assay of methanol/dichloromethane (1:1) root extract from 





Conc. % Viability SD 
 
100 2.0 81.83 0.48 
10 1.0 93.32 1.11 
1 0.0 96.75 3.12 
0.1 -1.0 94.48 2.59 
0.01 -2.0 100.54 3.03 
 
The methanol/dichloromethane root extracts from T. violacea were tested on the WI-
38 cell line from a higher concentration to a lower concentration. The results obtained 
were >5 μg/mL from the higher concentration to the lower concentration, as shown in 
Table 3.7. These results indicate that the methanol/dichloromethane root extracts from 







© Central University of Technology, Free State
41 
 










100 2.0 75.99 0.08 
10 1.0 96.56 2.00 
1 0.0 100.62 2.71 
0.1 -1.0 101.64 0.28 
0.01 -2.0 102.80 1.97 
 
The water root extracts from T. violacea were tested on the WI-38 cell line from a 
higher concentration to a lower concentration. The results obtained were >5 μg/mL 
from the higher concentration to the lower concentration, as shown in Table 3.8. These 
results displayed that the water root extracts from T. violacea were non-toxic when 
tested against the WI-38 cell line (Table 3.8). Madike et al. (2020) argued that the 
crude extracts of the roots from T. violacea also showed that cell viability was reliant 
on both concentration and type of extract used. The number of viable cells decreased 
as the concentration of the water extracts increased.  
 
 
Table3.9 List of plant extracts used in the cytotoxicity assay against WI-38 cell line 
 
 
The aqueous and methanol/dichloromethane leaf, bulb and root extracts from T. 
violacea, at equal ratios, were tested against the WI-38 cell line, the normal human 
foetal lung fibroblast, as shown in Table 3.9. All extracts of T. violacea were non-toxic 
when tested against the WI-38 cell line. Madike et al. (2020) observed that the number 
of viable cells decreased as the concentration of the ethanolic extract increased on a 
different cell line. These cytotoxicity activity results indicated that the leaf, bulb and 
root extracts of the T. violacea were safe for cellular exposure compared to the 
N
o. 
Solvent Name of 
sample 
IC50 (µg/ml) 
1 Methanol/dichloromethane Leaf extract  >100 
2 Water Leaf extract >100 
3 Methanol/dichloromethane Bulb extract  >100 
4 Water Bulb extract >100 
5 Methanol/dichloromethane Root extract  >100 
6 Water Root extract >100 
7 Standard Emetine
  2.66 
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standard drug (Emetine), which was considered highly toxic, with an IC50 value of less 
than 5 µg/ml for WI-38 cell lines.  
 
3.5 Results of genotoxicity  
The formation of micronuclei was determined using NucRed nuclear stain and the 
ImageXpress microscope, as shown in Figure 3.1. It is clear from these results that 
extracts (Table 3.10) did not induce the formation of micronuclei except for 
methanol/dichloromethane (extract no 5), which could possibly be considered 
genotoxic. 
 
Table 3.10 List of plant extracts used in the genotoxicity assay against Vero cell 
Sample 
No. 
Part Extraction solvent 
1 Bulb Methanol/dichloromethane  
3 Root Methanol/dichloromethane 
5 Leaf Methanol/dichloromethane  
9 Root Water 
10 Leaf Water 









Figure 3.1: Formation of micronuclei in response to treatment of Vero cells with varying 
concentrations (as indicated) of extract. Error bars indicate standard deviation from 
quadruplicate values.  
In Figure 3.1 there were 7% micronucleated cells that falsely indicated an induced 
micronucleus even at 0 μg/ml. This could be attributed to the incubation conditions. In 
the water extracts of the leaf and bulb there was a 1% increase to the negative control, 
which could also be ignored as one takes error bars into consideration. The DNA 
damage attributed to all extracts except methanol/dichloromethane on leaf is of less 
significance.  Comparing water leaf extract, which showed no genotoxicity, with the 
methanol/dichloromethane extract on leaf, it can be concluded that 
methanol/dichloromethane contributed to the genotoxicity.  The results of this study 
correlated well with the findings of the study by Madike et al. (2019) that reported a 
higher percentage of micronucleated cells after testing with the stem extracts 
compared to the leaf and root extracts. These results support the use of T. violacea, 
as it failed to induce DNA damage to the Vero cells, but it cannot be ignored that 









































The aqueous and methanol/dichloromethane extracts of T. violacea were non-toxic 
when tested against the WI-38 cell line. According to the criteria of the CSIR, the 
sample can be estimated as posing a low hazard if the value of IC50 is more than 100 
µg/ml. Furthermore, the aqueous and methanol/dichloromethane extracts of 
T. violacea were not genotoxic, as they failed to induce the formation of micronuclei 
and all could not be considered genotoxic. This finding indicates that further testing 
can be performed to determine the antioxidants and total phenols of T. violacea. The 
results of genotoxicity and cytotoxicity correlated and supported the safety of the plant 
for human consumption. This further confirms the safety of T. violacea when used by 
people for the treatment of diseases. 
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Antioxidant and total polyphenol analysis of Tulbaghia 











The preservation of pro-oxidant and antioxidant homeostasis in living cells is the 
primary focus of current research in the field (Olorunnisola et al., 2011). Many studies 
of plant phytochemicals evidenced that phytochemicals with antioxidant activity 
improve health and combat disease (Kaneria et al., 2009; Fawole et al., 2012). The 
imbalance in pro-oxidant and antioxidant homeostasis caused by excessive free 
radical generation or inadequate antioxidants is implicated in the development of 
several human disease conditions, such as atherosclerosis, high-tension ischaemic 
diseases, Alzheimer’s disease, Parkinsonism and cancer (Tlili et al., 2013). Pro-
oxidants are free radicals (superoxide, nitric oxide and hydroxyl radicals) produced in 
normal or pathological cell metabolism and through exogenous causes, such as 
human exposure to ionising radiation, injury, oxidative drugs and pollutants 
(Olorunnisola et al., 2011; Elisha et al., 2016; Takaidza et al., 2018). 
 
Medicinal plants have bioactive non-nutrient and biologically active compounds 
identified as phytochemicals, which contain a broad spectrum of chemical structures 
and protective/disease preventative properties (Madike et al., 2017). Phytochemicals 
are natural and important bioactive compounds formed by plants. They act as safety 
agents against external stress and pathogenic attack (Pandey and Kumar, 2013). 
Phytochemicals can be important natural antioxidants that can save the human body 
from free radicals (Soni and Sosa, 2013). Phenolics are some of the important 
antioxidants of phytochemicals produced by plants (Naczk and Shahidi, 2004). They 
are more effective because they have the potential to chelate metal ions, prevent lipid 
peroxidation and free radical scavenger properties (Tlili et al., 2013). Studies have 
reported that phenolic compounds such as caterchin and quercetin were enough to 
stabilise phospholipid bilayers against peroxidation induced by ROS (Perkins et al., 
2012; Soni and Sosa, 2013). 
 
The determination of the bioactivity of plant extracts or natural products, as well as 
synthetic compounds, whether antioxidant, antimicrobial, cytotoxic etc., is a crucial 
element in the discovery of new and improved therapeutic entities (Pisoschi and 
Negulescu, 2011). Many health benefits are associated with antioxidants, which 
provide protection against the development of diseases caused by oxidative stress 
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(Masoko, 2017). In addition to antioxidants, polyphenols have been emerging as one 
of the major natural products of importance to human health (Zhang et al., 2006; 
Longhini et al., 2017). Antioxidant and total phenolic compounds can remove free 
radicals, chelate metal catalysts, activate antioxidant enzymes, reduce alpha-
tocopherol radicals and inhibit oxidases (Brasileiro et al., 2015). Evidence has shown 
that polyphenols are good antioxidants and are effective in preventing cardiovascular 
and inflammatory diseases, as well as serving as anticancer agents (Adebayo et al., 
2015).  
 
African people occasionally visit public health facilities, where medication and 
treatments are frequently very expensive for their standard of living (Gismondi et al., 
2013). Numerous researchers and dietary organisations recommend an increase in 
the use of medicinal products of plant origin (Rates, 2001). Currently, about 64% of 
the total worldwide population remain reliant on herbal medicine for their healthcare 
needs (Tlili et al., 2013). There has been an increase in interest in potential antioxidant 
activity, as well as the total phenolic content, of plant and natural products (Atanassova 
et al., 2011). Hence, in this study the antioxidant potential and total phenolic 
constituents of the T. violacea plant will be determined. The antioxidant potential of 
the extract demonstrated by 1,1-diphenyl-2-picrylhydrazyl (DPPH) is designated by 
their IC50 and compared with that of the standard. The total phenolics and antioxidant 
screening of the plant is a prerequisite for authentication and utilisation of new sources 
of drugs of natural origin (Otang et al., 2012). 
 
4.2. Methodology 
4.2.1 Preparation of plant material 
The plant material of T. violacea was authenticated by scientists at the National 
Botanical Garden in Bloemfontein, South Africa. The collected material was washed 
to remove soil and then separated into leaves, bulbs and roots. The plant parts were 
oven-dried at 30-60 ºC for five days. The dried plant parts were weighed for extraction, 
ground to a coarse powder using a hammer mill and stored at ambient temperature 
prior to extraction. The dried and ground plant materials were blended in part of the 
extraction solvent (water and methanol/dichloromethane 1:1) using the Waring 
blender. After blending the rest of the solvent was added and solutions were allowed 
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to steep for 24 h. After 24 h the solids were removed from each solution by filtration 
with a Millipore funnel with medium filter paper (Bright sign no 102) connected to a 
Millipore vacuum pump. The organic extracts were concentrated by rotary vacuum at 
50-60ºC, then further dried in vacuo at ambient temperature. The aqueous extracts 
were concentrated to dryness using a freeze-dryer. The plant extracts generated were 
stored in a cold room at -20 ºC until further use. 
 
4.2.2 Assessment of antioxidant activity using the DPPH assay 
 
In a 96-well plate 5 µL sample, 120 µL Tris-HCL buffer (50 mM, pH 7.4) and 120 µL 
freshly prepared DPPH (0.1 mM in ethanol) were added and allowed to incubate for 
20 minutes in the dark at room temperature.  The absorbance was measured at 
513 nm using a BioTek® PowerWave XS spectrophotometer (Winooski, VT, USA) and 
the percentage radical scavenging activity was calculated as follows: 
   
% DPPH scavenged = (blank-sample)/blank   x 100. 
 
For the blank/control, buffer was substituted as the 5 µL sample.  Plant extracts were 
tested at final concentrations of 250 and 500 µg/mL.  Quercetin was used as a positive 
control at final concentrations of 6.25 - 25 µM.  
 
4.2.3 Total phenolic determination using the Folin-Ciocalteu assay 
A standard curve was prepared using gallic acid at a concentration range of 6.25 
µg/mL – 100 µg/mL. It is important to note that all extracts and the standard control 
(gallic acid) were prepared at 10 times the desired concentrations in consideration of 
the dilution factor of 1:10. Sample extracts (stock = 100 mg/mL) were prepared at a 
concentration of 10 mg/mL and centrifuged at 12 000 X g for 10 minutes. Thereafter, 
20 µL of supernatant was added to wells of 96-well plates, in triplicate. Dilutions of 1:1 
and 1:10 of the supernatant of each extract were also prepared. Then 100 µL of FC 
reagent was added to each well and the plate was incubated for 5 minutes at room 
temperature. An aliquot of 80 µL of 7.5 % Na2CO3 was added slowly to each well and 
the plate was left to incubate at room temperature in the dark for 2 h. The absorbance 
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was then read at 750 nm using a BioTek® PowerWave XS spectrophotometer 
(Winooski, USA). 
 
4.3 Results and discussion 
 
4.3.1 Assessment of antioxidant activity using the DPPH assay 
The results of this assay are displayed in Table 4.2, clearly showing the percentage 
DPPH scavenging activity of each extract.  
 
Table 4.1 List of plant extracts used in the DPPH and total phenolic assay against 
Vero cell 
Sample No. Part of plant Extraction solvent 
1 Bulb Methanol/dichloromethane  
3 Root Methanol/dichloromethane 
5 Leaf Methanol/dichloromethane  
9 Roots Water 
10 Leaf Water 
12 Bulb Water 
 
DPPH is a stable free radical at room temperature. It produces a violet solution in 
ethanol. When the free radical reacts with an antioxidant, it loses its free radical 
property as a result of the reaction, as it obtains an electron or hydrogen from the 
antioxidant to become a stable molecule and it changes colour to pale yellow (Olutayo 
et al., 2013). In the present study, extracts that produced a yellow colour were 
considered to have antioxidant properties.  The antioxidant activities of extracts from 
the leaf, bulb and root extracts from T. violacea were evaluated using the percentage 
scavenging activities (Table 4.2). 
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1 – Methanol/dichloromethane bulb extract; 3 – Methanol/dichloromethane root extract; 5 – 
Methanol/dichloromethane leaf extract; 9 – Water root extract; 10 – Water leaf extract; 12 – Water bulb extract. 
Among the extracts, the leaf water extracts of T. violacea had the highest scavenging 
activity, with the bulb methanol/dichloromethane extracts displaying the lowest 
scavenging activity. The crude extract of T. violacea seemed to be as effective as 
quercetin, with a maximum inhibition of 88.96% at 25 µg/ml, which is comparable to 
86.43% for quercetin at 25 mM concentration. The extract of T. violacea displayed 
high antioxidant activity compared to the standard. These results correlate with a study 
by Takaidza et al. (2018), which showed that T. violacea had the highest scavenging 
activities with both DPPH [0.01 (43% ) to 0.5 mg/mL (57%)] and ABTS [0.01 (46%) to 
0.5 mg/mL  (70% )], compared to other Tulbaghia species.  
 
 
4.3.2 Total phenolic determination 
 
The absorbance of the standard compound (gallic acid) at λmax =750 nm in 
T. violacea is presented in Table 4.3 and the standard calibration curve for 
quantification of total phenolic content is shown in Figure 4.1.  
 
Extract Concentration (µg/mL) 
% DPPH 
scavenged* Std Dev 
1 250 56.56 10.20 500 75.34 4.76 
3 250 82.62 1.82 500 85.91 4.30 
5 250 71.59 8.64 500 73.62 20.56 
9 250 58.44 4.45 500 66.19 5.14 
10 250 88.9 0.30 500 88.49 1.07 




6.25 µM 48.65 9.71 
12.5 µM 84.35 1.08 
25 µM 86.43 0.65 




Figure 4.1: Standard curve for total phenolics determination using the FC assay and gallic acid as the 
standard control.  
Table 4.3 shows the content of total phenols that were measured by Folin-Ciocalteu 
reagent in terms of gallic acid equivalent (standard curve equation: y = 0.0217, R2 = 
0.9816; Figure 4.1). The total phenolic content for the water extracts was found to be 
21.75, 10.94 and 10.94 µg/mL in the leaf, bulb and root extracts, respectively. In the 
methanol/dichloromethane extracts, the total phenolic content was found to be 20.28, 
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Table 4.3: Total phenolics determination using the FC method 




Std dev of 
concentration 
(µg/mL) 
1 0.17 7.93 0.12 
3 0.29 13.26 1.09 
5 0.44 20.28 0.98 
9 0.24 10.94 1.46 
10 0.47 21.75 0.88 
12 0.24 10.94 0.83 
1 – Methanol/dichloromethane bulb extract; 3 – Methanol/dichloromethane root extract; 5 – 
Methanol/dichloromethane leaf extract; 9 – Water root extract; 10 – Water leaf extract; 12 – Water bulb extract. 
  
 
The amount of total phenolics varied in different accessions and ranged from 7.93-
10.94 µg/ml. Total phenolic determination is indicated in Table 4.3, showing that 
aqueous leaf extract possessed the highest concentration of phenolics and 
methanol/dichloromethane bulb extract the lowest. According to Madike et al. (2017), 
the total phenolic content for the water extracts was 3.59, 2.38 and 1.91 mg/g in the 
leaf, stem and roots. The total phenolic content was 0.98, 0.34 and 0.15 mg/g in the 
leaf, stem and root extracts when 70% ethanol was used as one of the extracting 
solvents. The study by Madike et al. (2017) indicated that pharmacologically active 
compounds such as tannins, terpenoids, flavonoids, saponins, proteins, steroids, 
cardiac glycosides, phenols and coumarins were present in some parts of T. violacea. 
However, phlobatannins, leucoanthocyanins, alkaloids, carbohydrates and 
anthocyanins were absent in all plant parts. The leaves of the plant contained more 
active compounds than those present in the stems and roots in cases where water 
and 70% ethanol extracts. It can therefore be assumed that T.violacea extracts  used 
in this study contain pharmacological compounds and water leaf extract can be 
assumed to have more, as it has the highest antioxidant and phenolics concentration, 








The study showed that both the aqueous and methanol/dichloromethane extracts of 
T. violacea possessed antioxidant activity properties. Furthermore, for total phenolic 
determination, both the aqueous and methanol/dichloromethane extracts have 
potential. It is well recorded that phenolic compounds contribute to quality and 
nutritional value in terms of adapting colour, taste, aroma and flavour and in providing 
benefits to health. They also play a role in plant defence mechanisms to counteract 
ROS, to endure and avoid molecular damage and damage by microorganisms, 
insects, and herbivores (Sengul et al., 2009). Further testing to determine the 
antimicrobial effect of T. violacea will be performed on organisms that are highly 
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South Africa is an emerging nation with a big rural population that depends on plant-
based resources for many purposes, for example building, craftwork, food, cosmetics 
and remedies. The diversity of cultural groups in South Africa has given rise to a 
melting pot of cultural indigenous knowledge, from the ‘boererate’ of the Afrikaans 
community and the cultural knowledge of the Khoikhoi and San tribes in the Karoo 
region, to the cultural knowledge of the Zulu, Xhosa, Basotho and Venda people, 
across the Republic (Corrigan et al., 2011). Medicinal herbs are now globally known 
as the basis for several critical human health, social, and economic support systems 
and benefits (Street and Prinsloo, 2013). Traditional herbs are commonly used by 
South African traditional healers to treat a range of diseases, such as malaria and its 
related symptoms. South Africa boasts great biodiversity and rich cultural traditions of 
plant use (Clarkson et al., 2004). It is estimated that 60% of the South African 
population use herbal plant as medicines for primary health care treatments (Ncube 
et al., 2011). 
Naturally occurring constituents of plant, animal and mineral sources have provided 
an ongoing source of medicine to man since ancient times, but it is the plant kingdom, 
specifically, which has proven to be of most use for treating several diseases (Ahmad 
et al., 2001; Mahesh and Satish, 2008). Throughout history, investigation has 
succeeded in distinguishing those plants that have valuable effects from those that are 
toxic or merely ineffective (Heyman et al., 2009). Through trial and error, human 
beings have discovered ways of relieving pain and sickness, and of living in harmony 
with nature (Nielsen et al., 2012). Medicinal plants have been used as a remedy for 
many years, playing an important role in drug discovery and development (Rabe and 
van Staden, 1997; Heyman et al., 2009; Madureira et al., 2012). Medicinal plants play 
a significant role in the primary health system in South Africa, with an estimation of 
about 80% of the black population still consulting traditional healers for treatment 
(Heyman et al., 2009; Adebayo et al., 2015 Ghuman et al., 2016; Madikizela et al., 
2017). The significance of plant products is evident in the treatment of infectious 
ailments, where over 60% of antimicrobial agents are of plant origin (Mishra et al., 
2017).  
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Antibiotics have been broadly accessible for many years; they have had a huge impact 
on medical practitioners’ capability to treat bacterial diseases globally. Nevertheless, 
in the past 40 years only three new classes of antibiotics have been developed, mostly 
for medicines used in winter (lipopeptides, oxazolidinones and streptogramins), all 
geared towards Gram-positive bacterial infections. A deficiency of new antibiotics for 
the treatment of Gram-negative infections, combined with emerging multi-drug 
resistance problems, stresses that new antibacterial approaches need to be 
discovered for treating these infections (Marr et al., 2006).  
The great number of plant product-derived antibiotics may be due, in part, to the 
development of secondary metabolites as a defence strategy against environmental 
stresses (Madureira et al., 2012). This feature, coupled with their enormous structural 
diversity and great biodiversity, makes plant products an important and interesting 
subject in drug discovery and development (Bisi-Johnson et al., 2017). It is estimated 
that infectious ailments are directly causing 26% of annual deaths globally (Masoko, 
2017). The influence of bacterial ailments is important in Africa, were drugs are 
inadequate and the development of drug resistance has made numerous currently 
available drugs ineffective (Dzoyem et al., 2016). Bacterial resistance to antibiotics is 
a serious and increasing problem of public health, representing a worldwide threat 
(Levy et al., 2004). Certainly, infectious diseases are becoming more problematic to 
treat because of multi-drug-resistant bacteria, especially Gram-positive pathogens 
(Engler et al., 2012). 
It is projected that by the year 2050, infections by antimicrobial-resistant bacteria will 
be the leading cause of death globally (van Vuuren and Muhlarhi, 2017). Significant 
bacterial strains against which transmission resistance is found include among others 
S. aureus, Pseudomonas aeruginosa, Acinetobacter baumannii and K. pneumoniae 
(Magiorakos et al., 2012). In South Africa, antibacterial resistance has reached a 
disturbing scope (van Vuuren and Muhlarhi, 2017). The usage of medicinal plants has 
lately fascinated researchers. This has involved the isolation and identification of 
secondary metabolites produced by herbs and their usage as active principles in 
therapeutic preparations (Das et al., 2010). Studies have shown that more than 50% 
of all hospital-acquired S. aureus infections were of methicillin resistance origin 
(Mulaudzi et al., 2010). In various parts of the globe, herbal plants are used for the 
treatment of antibacterial, antifungal and antiviral diseases. These plant extracts are 
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used as the basis of therapeutic agents to treat urinary tract infections, cervicitis 
vaginitis, gastrointestinal illnesses and skin infections such as herpes simplex virus 
type I (Essawi and Srour, 2000). Therefore, there is a great need to screen medicinal 
plants for potential and effective antibacterial drugs against resistant strains (Masoko, 
2017). 
Antibacterial assays are important to test and screen inhibitory effects on test 
microorganisms. In this study, a representative of a Gram-positive and one of a Gram-
negative bacterium were used, namely S. aureus and K. pneumoniae, respectively. It 
is important to include a known antibacterial agent as a positive control for these 
assays to enable direct comparison of extracts and to ensure that the assay was 
performed successfully.  
 
5.2 Methodology 
5.2.1 Preparation and extraction of plant material 
The plant material of T. violacea was authenticated by scientists at the National 
Botanical Garden in Bloemfontein, South Africa. The collected material was washed 
to remove soil and then separated into leaves, bulbs and roots. The plant parts were 
oven-dried at 30-60ºC for five days. The dried plant parts were ground to a coarse 
powder using a hammer mill and stored at ambient temperature prior to extraction. 
 
The dried and ground plant materials were blended in part of the extraction solvent 
(water and methanol/dichloromethane 1:1) using the Waring blender. After blending 
the rest of the solvent was added and solutions were allowed to steep for 24 h. After 
24 h the solids were removed from each solution by filtration with a Millipore funnel 
with medium filter paper (Bright sign no 102) connected to a Millipore vacuum pump. 
Organic extracts were concentrated by rotary vacuum at 50-60ºC, then further dried 
in vacuo at ambient temperature. The aqueous extracts were concentrated to dryness 
using a freeze-dryer. The plant extracts generated were stored in a cold room at -20ºC 
until further use (Table 5.1). 
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Table 5.1 List of plant extracts used in the antibacterial activity against S. aureus 
and K. pneumonia 
Sample 
No. 
Part of plant Extraction solvent 
1 Bulb Methanol/dichloromethane  
3 Root Methanol/dichloromethane 
5 Leaf Methanol/dichloromethane  
9 Roots Water 
10 Leaf Water 
12 Bulb Water 
 
5.2.2 Determination of antibacterial activity of extracts using the p-
Iodonitrotetrazolium chloride assay 
 
The antibacterial activity of plant extracts was tested on S. aureus (ATCC 11632) and 
K. pneumoniae (ATCC 10031), representatives of Gram-positive and Gram-negative 
bacteria, respectively. Bacterial cultures were grown on Mueller-Hinton (MH) agar 
plates at 37°C. An overnight streak plate was used to inoculate MH broth (Merck, USA) 
and this was allowed to grow for 16 h (log phase) at 37°C. Gentamicin sulphate and 
vancomycin hydrochloride (Sigma, USA) were used as positive controls against K. 
pneumoniae and S. aureus, respectively. Antibiotics were dissolved in double-distilled 
water at stock concentrations of 2 mg/mL and filter-sterilised (0.2 µm filter). Working 
concentrations of the antibiotics were prepared in MH broth, depending on the 
minimum inhibitory concentration (MIC) value.  
 
Thereafter 40 µL of MH broth was added to the wells of a sterile 96-well plate and 
50 µL of test extracts were added to the relevant wells. This was followed by a serial 
dilution of extracts to achieve the concentration range, as indicated in Figures 5.1 and 
5.2. The cultures were assessed and adjusted to a 0.5 McFarland standard [1.175% 
BaCl2 and 1% H2SO4 with absorbance 600 nm = 0.08-0.1 to achieve ±1.5 x 108 
cells/mL]. A 50 µL aliquot of the relevant bacteria was added to each test well. Plates 
were sealed and incubated at 37˚C for 24 h; p-Iodonitrotetrazolium chloride (INT) was 
prepared at a working concentration of 0.2 mg/mL in ddH2O and filter-sterilised (0.2 
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µm filter). Then, 50 µL of INT was added to each well and the plates were further 
incubated for 30–60 minutes at 37˚C until a colour change was observed (yellow to 
pink/purple to indicate the reduction of the dye by viable bacteria). No colour change 
indicated the inhibition of bacterial growth. Absorbance (abs) was measured at 600 nm 
using a BioTek® PowerWave XS spectrophotometer (Winooski, USA).  
 
Percentage inhibition was defined as: Percentage inhibition = 1 – (test well abs/mean 
abs triplicate bacteria only well) x 100. 
 
5.3 Results and discussion 
 
The antibacterial activity of indicated extracts was tested against a Gram-negative and 
Gram-positive bacterium. Figures 5.1 below show the antibacterial activity of six 
extracts from T. violacea against S. aureus for a concentration range of 0.0156 mg/ml 
– 2 mg/ml.  Vancomycin was used as a positive control at its MIC of 2 µg/ml. As shown 
in Figure 5.1, dichloromethane extract 1 showed that MIC activity was dependent at 
extract concentrations against S. aureus. Dichloromethane extract no. 3 and water 
extract no. 9 did not inhibit bacterial growth at concentration ranging between 
0.0125 mg/mg-0.5 mg/ml, then did inhibit bacterial growth at concentration ranging 
between 1 mg/ml and 2 mg/ml against S. aureus.  Dichloromethane extract no. 5 and 
water extract no. 12 showed variation against S. aureus. Water extract no. 10 showed 
no MIC at all concentrations against S. aureus. Concerning extract no. 1, the 
antibacterial activity was dependent on the concentration. Extract no. 10 showed that 
the activity against S. aureus was dependent on the concentrations and type of solvent 
used. The antibacterial activity of six extracts from T. violacea against K.  pneumoniae 
for a concentration range of 0.0156 mg/ml – 2 mg/ml .   
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Figure 5.1: Screening for antibacterial activity of six extracts (as indicated) against S. aureus for a 
concentration range of 0.0156 mg/ml – 2 mg/ml.  Vancomycin was used as a positive control at its MIC 
of 2 µg/ml. Error bars indicate standard deviation of quadruplicate values determined in a single 
experiment. 
 
Gentamicin was used as a positive control and inhibited bacterial growth at MIC of 2 
µg/ml as shown in Figure 5.2. All extracts showed unreliable fluctuating activities, 
except no. 10, which exhibited more concentration-dependent activity. This indicates 
that extract no. 10 did inhibit K. pneumoniae and did not exhibit any activity against 
S. aureus. The study that was done by Ncube et al. (2011) showed that the best 
antibacterial activities were reported in the winter season from the dichloromethane 
bulb extracts of T. violacea against S. aureus and K. pneumoniae having an MIC value 
of 0.2 mg/ml. This correlates with dichloromethane extract no. 1 and extract no. 10. 
 
Effective results of botanical compounds from plant materials are greatly reliant on the 
type of solvent used in the extraction procedure. Traditional healers use mainly water 
as the solvent, but in this and other studies, the researcher observed that the organic 
solvent extracts exhibited a greater antibacterial activity than water extract. These 
remarks can be rationalised in terms of the polarity of the compounds being extracted 
by each solvent and in addition to their intrinsic bioactivity, their capability to dissolve 
or diffuse in the different media used in the assay (Das et al., 2010).  
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Figure 5.2: Screening for antibacterial activity of six extracts against K. pneumoniae for a concentration 
range of 0.0156 mg/ml–2 mg/ml.  Gentamicin was used as a positive control at its MIC of 2 µg/ml. Error 

















The extracts from T. violacea were active against S. aureus and K. pneumoniae at the 
concentrations used in this study. The antibacterial activity showed interesting results, 
with certain plant extracts indicating Gram-specificity. Extracts 10 and 12 from 
T.  violacea both showed activity against K. pneumoniae (Gram-negative) but not 
against S. aureus (Gram-positive). Extract 9 showed a similar result at lower 
concentrations. The high concentrations of extract 3 showed a more drastic increase 
in the percentage cell death of S. aureus than of K. pneumoniae. Extract 1 also 
seemed to be effective against S. aureus. The extracts of T. violacea have the potential 
to be developed as an antimicrobial agent, but the standard displays more 
antimicrobial activity. 
The investigated plant extract of T. violacea showed that the results obtained confirm 
the therapeutic potency of some plants used in herbal therapy. In addition, these 
results form a good foundation for the selection of candidate plant species for further 
phytochemical and pharmacological investigation. The results of the present 
investigation support the usage of the studied extract and suggest that some plant 
extracts contain compounds with antibacterial properties that can be used as 
antimicrobial agents in new drugs for the treatment of infectious ailments caused by 
pathogens. The most active extracts can be exposed to isolation of therapeutic 
antimicrobials and undergo further pharmacological assessment. 
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6.1. Introduction   
This chapter is a summative assessment of the conclusions drawn from the research 
study, as well as the answers to the research aim and objectives. Recommendations 
were also drawn from the data obtained; these conclude the thesis.   
 
6.2. Conclusion  
  
The evaluation of the phytochemistry and biological activity in plant extracts is a 
primary phase essential for finding and developing new remedies with improved 
efficacy. The phytochemistry and biological activity presented in T. violacea suggest 
that the plant is a potential source of chemotherapeutic agents. In this study, most of 
the phytochemistry and biological activity were found in the leaves of T. violacea, 
authenticating their traditional use in the treatment of various ailments such as fever, 
colds, asthma, tuberculosis, oesophagus cancer, high blood pressure and stomach 
problems such as gastroenteritis, as well as abdominal pains. The two solvents used 
in this research were able to extract different bioactive compounds. 
 
The leaves, bulb and root extracts from T. violacea were evaluated against the human 
cell lines TK-10 (renal), PC3 and HeLa. All extracts were inactive. A higher 
concentration of aqueous and methanol/dichloromethane extracts were chosen and 
used against these three human cell lines. The aqueous solvent proved to be the 
solvent of choice to perform extraction on the T. violacea plant. Furthermore, the leaf 
extract would be the best part of the plant to test against TK-10, PC-3 and HeLa human 
cell lines. The values of IC50 for two to three cell lines showed inactivity (>100 µg/ml) 
of T.  violacea plant extracts. Water was a much safer extraction solvent than 
dichloromethane solvent because the crude water extracts did not exhibit an 
undesirable IC50 value at a low concentration. The aqueous extract of the leaf supports 
the claims made by traditional healers for their use of the T. violacea plant for the 
treatment of cancer and other diseases. 
 
The findings of the study demonstrated that crude aqueous and 
methanol/dichloromethane extracts prepared from the leaves, bulbs and roots of T. 
violacea were not toxic at all concentrations. This further confirms the safety of 
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T. violacea when used for the treatment of diseases. This research provided 
preliminary data on the toxicity of crude extracts from T. violacea plant parts towards 
WI-38 cell lines. The results demonstrated that all extracts are not cytotoxic at 
concentrations higher than 100 μg/ml.  According to this study, a concentration of 10 
to 100 μg/ml from the water extracts of T. violacea plant parts may be considered the 
optimal dosage for preparation of traditional remedies. The study also supports the 
traditional use of only T. violacea leaves for the preparation of remedies to treat various 
ailments owing to the reported high percentage cell viability, as well as the desirable 
IC50 value. There is thus no need to harvest the other parts of T. violacea for 
preparation of traditional medicines. This is important for the conservation of species. 
This study supports the use of water as an extraction solvent, which is in line with the 
traditional method of extraction. Furthermore, aqueous and 
methanol/dichloromethane extracts of T. violacea were not genotoxic, as they failed 
to induce the formation of micronuclei. The results of genotoxicity and cytotoxicity 
correlated with and supported the safety of the plant for human consumption. 
 
The study presented that both the aqueous and methanol/dichloromethane extracts of 
T. violacea possessed antioxidant activity potential. Furthermore, for total phenolic 
determination, both the aqueous and methanol/dichloromethane extracts displayed 
potential. It is well recorded that phenolic compounds contribute to quality and 
nutritional value in terms of adapting colour, taste, aroma and flavour and in having 
effects beneficial to health. They also play a role in plant defence mechanisms to 
counteract ROS, to endure and avoid molecular damage and damage by 
microorganisms, insects, and herbivores (Sengul et al., 2009).  
 
This study indicated that water and methanol/dichloromethane extracts from T. 
violacea were active against S. aureus and K. pneumoniae at different concentrations 
used. The water leaf extract and water bulb extract from T. violacea both showed 
activity against K. pneumoniae (Gram-negative) but not against S. aureus (Gram-
positive). The water root extract showed a similar result at lower concentrations. The 
high concentrations of methanol/dichloromethane root extract showed a more drastic 
increase in the percentage cell death of S. aureus than of K. pneumoniae. 
Methanol/dichloromethane bulb extract also seemed to be effective against S. aureus. 
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The extracts of T. violacea have the potential to be developed as an antimicrobial 
agent, but the standard displays more antimicrobial activity. 
 
The T. violacea extracts studied yielded results confirming the treatment effectiveness 
of some plants used in medicinal remedies. In addition, these results lay the essential 
groundwork for the selection of candidate plant species for further phytochemical and 
pharmacological investigation. The results of the present study support the usage of 
the studied extract and suggest that some plant extracts contain compounds with 
antibacterial properties that can be used as antimicrobial agents in new drugs for the 
treatment of infectious ailments caused by pathogens. The most active extracts can 
be exposed to isolation of therapeutic antimicrobials and undergo further 
pharmacological assessment. This study proved that different factors affect the 
quantity and composition of the phytocompounds present in an extract, such as the 
nature of the solvent, the concentration and the polarity of the solvent used. Overall, 
this research study also supports the ancient and frequent use of only leaf water 
extracts of T. violacea for research purposes and for the preparation of herbal 
remedies.  
 
6.3. Recommendations   
The quantitative/semi-quantitative analysis of the present phytochemistry and 
biological activity in the T. violacea plant parts will be an interesting area for further 
study (Madike et al., 2017). Further investigation is required to exploit the biomedical 
applications of T. violacea. Further testing using other cancer cell lines is required, 
also to identify the active compounds of T. violacea plant extracts. Further testing to 
determine the antimicrobial effect of T. violacea will be performed on organisms that 
are highly successful opportunistic pathogens and thus involved in various diseases. 
T. violacea plant extracts are rich in cardiac glycosides, which have been described to 
increase sodium ion levels in the myocytes, thus leading to a rise in the level of calcium 
ions, promoting an increase in calcium ions available for contraction of the heart 
muscle, which improves cardiac output and decreases distention of the heart 
(Takaidza et al., 2018). The anti-HIV activity of saponins (Ncube et al., 2011) is an 
interesting area for further research, as their presence was found in all the plant parts 
of T. violacea. Research should be conducted too to isolate, identify, characterise and 
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eluidate the structure of the identified bioactive compounds from T. violacea. To 
broaden this research, different extraction methods should be considered for further 
verification of the results obtained in this study. These may include infusion, 
percolation, digestion, decoction, hot continuous extraction (Soxhlet), counter-current 
extraction, microwave-assisted extraction, ultrasound extraction (sonication), 
supercritical fluid extraction, etc. (Patel et al., 2018). In vitro studies have stated that 
flavonoids possess antiviral activity against several viruses, among others poliovirus. 
This emphasises the need to research T. violacea leaf extracts for the likely remedy 
of polio, as they are rich in flavonoids (Longhini et al., 2017). The use of different 
solvents may also be considered, as solvents are selective for the extraction of specific 
compounds. Extraction solvents such as acetone, chloroform, ether, butanol or 
methanol may be used. Furthermore, it would be significant to distinguish the effects 
of the non-toxic concentrations on the cytokine and chemokine profiling of the 




















Appendix 1:  
Antibacterial activity against selected micro-organisms 
The antibacterial activity of indicated extracts were tested against a Gram-negative and Gram-positive 
bacterium, as discussed in the report. Figures 1 and 2 below show photographs of the result, as well 
as the plate layout of the experiment. From Figure 2 it is clear that Extract 1 has an MIC value of 2 
















Figure 1: Screening for antibacterial activity of extracts 1, 3, 5, 9, 10 and 12 against K. pneumoniae 
at a concentration range of 0.0156 mg/ml – 2 mg/ml.  Vancomycin was used as a positive control at 
its MIC of 2 µg/ml. 
 
 























Figure 2: Screening for antibacterial activity of extracts 1, 3, 5, 9, 10 and 12 against S. aureus at a 
concentration range of 0.0156 mg/ml – 2 mg/ml.  Vancomycin was used as a positive control at its 
MIC of 2 µg/ml. 
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